Request a Confidential Readiness Review
See how your company and program are represented in AI answers and where narrative clarity may be breaking down.
In one focused review, we assess how AI interprets your company, your program, and your supporting proof signals. This is designed to reduce narrative risk across investor conversations, business development outreach, and public information channels. NDA friendly. No obligation.
What We Review
- How your company and program appear in AI generated answers
- Where the narrative is unclear, inconsistent, or unsupported
- Which decision questions investors and partners may ask, and what AI returns
- Whether your public proof signals support trust
- The fastest improvements to improve answer accuracy and shortlist visibility
What You Receive
- A clear visibility and narrative assessment
- A prioritized action plan
- Guidance your team can implement quickly
- Optional ongoing support if needed after the review
Who This Is For
- •Founder-led clinical-stage biopharma companies
- •Investor-backed development programs
- •Teams preparing for partnering, diligence, or regulatory milestones
- •Organizations where interpretive precision matters
Request a Confidential Readiness Review
See how your company and program are represented in AI answers and where narrative clarity may be breaking down.
Request a Confidential Readiness Review
NDA friendly. Clear next steps.
We work from public and approved materials only. No proprietary data required.